Contact
Home / News / Pharma Lab Solution Provider for High-Throughput Dissolution Testing
Hot Tags
Recently

Pharma Lab Solution Provider for High-Throughput Dissolution Testing

By hqt
2026-09-22
Share:

High-throughput dissolution testing relies on a lab's ability to efficiently convert scheduled tests to reviewable results. There are a few factors which include the capacity of the vessels, the sample performance, analytical turnaround times, and the batch changeover times.

As a Pharma Lab Solution Provider, we integrate instrument design and method requirements to select equipment. This allows us to achieve a significant improvement in capacity through automation, sampling, and controlled ownership.

Define the Workload Before Specifying Capacity

Prior to recommending automation, a Pharma Lab Solution Provider requires a profile of the workload. This includes

•   Demand: routine and peak tests per shift, dosage forms, and method diversity.

•   Method conditions: apparatus, medium, volume, temperature, speed, and duration.

•   Sampling load: time points, withdrawal volumes, replacement requirements, and analytical method.

•   Operating constraints: staffing, available hours, cleaning time, and review capacity.

For example, if we have 12 vessels with six sampling points each, we would end up with 72 collected samples. Assuming we have chromatographic injectors which can take a 10 minute injection, we would need the instruments for a total of 12 hours to analyze all the samples, as well as take standard and blank injections and perform repeat analyses.

Consequently, a dissolution upgrade can shift the bottleneck downstream. Track completed tests per shift, hands-on minutes per test, and sample-to-reviewed-result turnaround alongside vessel utilization.

Locate the Constraint in the Complete Cycle

Ask your Pharma Lab Solution Provider to evaluate preparation, testing, sampling, analysis, cleaning, and review separately.

Distinguish elapsed time from analyst time. Automated sampling may free personnel while leaving the prescribed dissolution duration unchanged. Automated cleaning may shorten changeover only if the cleaning cycle is effective for the product and medium.

Measure the current process before estimating savings. Include warming, deaeration, setup checks, waste handling, and unsuccessful runs.

Compare Automation Against Method Diversity

A Pharma Lab Solution Provider should compare operating models using consistent criteria.

ConfigurationBest-Fit WorkloadMain Throughput BenefitTechnical and Cost Trade-Off
Manual testingLow volume; frequent method changesFlexible setup and lower initial investmentGreater analyst dependence and time-point coordination
Parallel vessels with automatic samplingRepeated methods; substantial sampling demandParallel testing and reduced sample handlingSampling-cycle limits, collection capacity, and downstream analytical queues
Multi-batch automationMature methods; recurring batchesReduced intervention during batch transitionsHigher investment, cleaning qualification, consumables, and exception management

More vessels only help if methods and resources allow for parallel operation. One challenge with automating more than one batch at a time is finding a way to incorporate media handling, dosing, and cleaning as well as the next test in the assay.

Online UV may eliminate the need for offline analysis as long as selectivity is sufficient. For chromatographic separations, you need to verify the stability of the samples you are collecting.

Addressing Sampling Bias When Increasing Analysis Throughput

Analysis of Fluid Path Recovery and Timing

When shifting from a manual to an automated sampling system, you must consider things like tubing adsorption, filter suitability, the settings of the pumps used for both cleaning and sampling, sampling bias, the probe position, and the hydrodynamics of the vessels. These are the major challenges of an automated sampling system that must be addressed during system validation.

A Pharma Lab Solution Provider should be able to explain:

•   Recovery: How long it took to concentrate the sample, and possible adsorption from the tubing and filter

•   Timing: The time the sample was withdrawn and the time it was taken to be in the collection vial

•   Volume balance: The sample volume, flush volume, and volume of the replacement medium

•   Carryover: The adequacy of the cleanup method using a representative product and medium

Establish acceptance criteria for the method, and then compare manual and automated results.

Equipment and Electronic Records

Verify mechanical setup and operating conditions through the laboratory's qualification and maintenance program. For electronic records, evaluate sample identity, original data, access controls, audit-trail review, and retrieval.

Supplier software claims do not replace assessment of the configured workflow, procedures, and user responsibilities.

Raytor Design Choices for Different Bottlenecks

RT612-ST: Parallel Testing and Automated Sampling

Our RT612-ST combines 12 vessels, automatic preheating, synchronized dosing, online filtration, and sample collection. Its coaxial paddle-and-basket arrangement permits method changes without readjusting dissolution-unit height, reducing a setup task while retaining required checks.

Top Pharmaceutical Dissolution Tester Manufacturers

Sampling schedules need particular attention: the published specification lists a three-minute first sampling point and five-minute subsequent routine sampling intervals. Confirm compatibility with the intended method before selection. RT612-ST product specifications

RT900 and RT910: Successive Batch Processing

Our RT9 series includes RT900 for paddle methods and RT910 for basket methods. Published features include ten consecutive batch tests, automated media distribution, and vessel cleaning.

USP Dissolution Testing is one of the clearest windows into how a tablet actually behaves after it leaves the bottle—because it measures drug release under controlled, repeatable conditions that can predict real-world performance risks before patients ever see them. 1) What is USP Dissolution Testing? USP Dissolution Testing is a consistent lab method for assessing the time course and extent of drug release from dosage forms—typically tablets and capsules—into a liquid medium with controlled test parameters. In plain terms: it answers, "Does this tablet release the medicine at the right rate, consistently?" What it’s used for: • Quality control (QC): confirm batch-to-batch consistency • Product development: compare formulations, coatings, excipients, and processes • Stability monitoring: detect performance changes over shelf life • Regulatory compliance: meet pharmacopeial/compendial requirements How it works (simple view): A tablet/capsule is placed in a vessel of dissolution medium (like simulated gastric/intestinal fluid) kept at 37°C. A standardized stirring tool—usually: • Paddle (Apparatus 2) or • Basket (Apparatus 1) spins at a set RPM. Samples are taken at defined time points and analyzed (often by UV or HPLC) to calculate % drug dissolved vs. time. What you get from the result: • A single-point pass/fail result (e.g., "Q = X% at 30 minutes"), or • A full dissolution profile (release curve) that reveals performance differences. 2) Why Tablet Performance Is More Than "It Dissolves" Many beginners assume dissolution is simply "does the tablet fall apart." In practice, tablet performance is a chain of events: wetting, disintegration, deaggregation, and then drug release into the medium. A tablet can look perfect and still release too slowly, too fast, or too inconsistently between batches. That is why compendial dissolution exists: USP Dissolution is used to determine compliance with dissolution requirements stated in monographs for tablets/capsules. When you run the method correctly, you are not just collecting numbers—you are testing whether formulation, compression, coating, and processing control are stable enough to deliver reliable release. From Raytor’s manufacturer perspective, we often describe dissolution data as a "performance fingerprint." If the fingerprint changes, something in the product or process changed—even if basic QC tests still pass. 3) What USP Dissolution Testing Reveals About Tablet Performance A well-designed dissolution profile can reveal problems that typical appearance or assay checks cannot. For oral tablets, it helps answer: • Does the tablet release at the intended rate, especially across time points? • Do batches behave the same under the same method? • Is the product sensitive to small process shifts (granulation moisture, compression force, coating weight gain)? Here are the practical "signals" you can learn to read: ✓ Release Speed And Risk: Too fast can increase variability or side effects; too slow can reduce therapeutic effect. ✓ Batch-to-Batch Consistency: When profiles drift, it often points to process instability. ✓ Formulation Robustness: A robust tablet keeps its profile even when raw material variation occurs. ✓ Manufacturing Control: Dissolution trends can expose subtle issues like lubricant over-mixing, binder changes, or coating defects. Dissolution is also part of a broader family of performance tests. For example, USP Drug Release is used where drug-release requirements apply (often for transdermal systems and other dosage forms). These chapters reinforce a key idea: performance testing is not "extra testing," it is how you prove the dosage form performs as designed. 4) The Variables That Most Affect Dissolution Results The easiest way to get confused with USP Dissolution Testing is to change several variables at once. A more reliable learning path is to control the basics first, then fine-tune. Key Variables You Should Control First Start with the factors that most commonly cause noise or false shifts: ✓ Temperature Stability: Small temperature drift can change viscosity and release rate. ✓ Agitation Accuracy: RPM stability matters as much as the setpoint. ✓ Timing Discipline: Dose timing and sample timing must be consistent. ✓ Sampling Pathway: Adsorption, carryover, and filtration can distort results. ✓ Media Handling: Degassing, preheating, and volume accuracy protect repeatability. Once those are stable, you can interpret tablet performance with more confidence. When those are unstable, you may end up "optimizing" the formulation to match a measurement problem, not a product problem. 5) How RT600-ST Turns USP Dissolution Testing Into Repeatable Daily Work In real QC environments, the challenge is not understanding the theory—it is producing consistent, audit-ready results day after day. That is where automation matters. Raytor’s RT600-ST Automated Dissolution System is built as an 8-position, single-drive, autosampling platform designed to meet major compendial requirements, including ChP (0931), USP (711/724), and EP (2.9.3/2.9.4). It supports automatic dosing, automatic positioning, automatic sampling, optional online dilution, and real-time display of speed and temperature—aiming for high precision with higher efficiency. Here is how specific design advantages translate into practical value for your team: • Automatic Preheating + Covered Dissolving Cups You can schedule constant-temperature water bath preheating and maintain uniform conditions. For beginners, this removes a major source of variability: inconsistent media temperature at start. • Automatic Synchronous Dosing Dosing time differences can create artificial profile differences. RT600-ST tracks dosing time so multiple vessels begin under the same timing logic. • High-Precision Sampling Pump + Optional Online Dilution Accurate sampling improves data trust. Optional online dilution helps labs handle high-concentration or challenging products without manual dilution mistakes. • Teflon Pipeline With High Chemical Stability And Anti-Adsorption Sampling lines can silently "eat" analyte through adsorption. A high anti-adsorption pathway helps protect low-dose or sticky APIs so your results reflect the tablet—not the tubing. • Dual Online Filters + Continuous Filtration Clogging is a real operational problem. Dual filters help reduce blockages and keep sampling stable, especially with formulations that shed particles. • Paddle-Basket Co-Axial Design (No Recalibration When Switching Methods) Switching between basket and paddle methods becomes simpler, reducing downtime and minimizing setup errors that beginners commonly make. • 120-Vial Automatic Sample Collection The sample tray capacity (up to 120 vials) supports longer runs, multiple time points, and higher throughput without constant operator interruption. If your goal is to learn what USP Dissolution Testing reveals about tablet performance, repeatability is everything. An automated, disciplined workflow makes the "reveal" trustworthy. 6) Beyond Tablets: Where USP Dissolution Testing Connects to Other Dosage Forms Although this article focuses on tablets, modern labs rarely test only one dosage form. RT600-ST is designed for broader application coverage, and the standards help guide that expansion. For example, USP Semisolid Drug Products—Performance Tests discusses developing in vitro performance tests to evaluate drug release or skin permeation for topical and transdermal semisolid and liquid-based products (creams, gels, patches, and more). This highlights an important mindset: performance testing is a toolkit, and dissolution/drug-release methods are part of a continuum. Common application directions include: • Oral Tablets (QC dissolution profiles) • Patches (drug release / dissolution approaches depending on monograph) • Semi-Solid Preparations (in vitro release and related performance concepts) • Injections (where relevant performance tests apply) • Intrinsic Dissolution Rate of API (material performance screening) 7) Data Integrity and Scale: From One Test to a Smarter Lab As throughput grows, the next bottleneck is not the vessel—it is data handling and instrument coordination. Raytor’s Data Cloud System is designed to connect at least 250 different types of experimental instruments for intelligent management across a lab network. This raises traceability and reduces time for cross-instrument review of dissolution changes and batch signals. CTA (For QC Teams and New Labs): Start right in 2026—Raytor will help map methods (USP/EP/ChP), select appropriate automation, and configure RT600-ST features—online dilution, filtration strategy, and sample collection—around your products. Reach out to request an application discussion, a configuration recommendation, or a demo plan tailored to your dosage forms.

These designs address repeated batch handling. Actual unattended operating time depends on method duration, consumable capacity, cleaning requirements, and fault handling. RT9 series product information

As a Pharma Lab Solution Provider, Raytor also offers dissolution accessories and customization services. This supports configuration discussions around the application; project-specific scope should be confirmed. Raytor dissolution solutions

Qualify the Investment Before Purchase

Evaluate a Pharma Lab Solution Provider through a representative workflow demonstration and documented acceptance criteria.

Request:

•   A user requirements specification covering current demand and planned expansion.

•   Defined equipment qualification, method-transfer, and validation responsibilities.

•   Demonstrated sampling, cleaning, interrupted-run recovery, and data export.

•   Training, service coverage, spare-part availability, and maintenance requirements.

Compare annualized equipment costs, software, consumables, service, qualification, labor, and downtime per completed test. Use realistic utilization rather than maximum advertised capacity.

Discuss Your Workflow with Raytor

Selecting a Pharma Lab Solution Provider starts with the method and the bottleneck. Explore Raytor's dissolution testing solutions and share your workload, sampling schedule, and analytical requirements with our team. We can discuss a configuration that supports practical capacity growth and dependable routine operation.

FAQs

Q1. What does Raytor offer as a Pharma Lab Solution Provider?

Raytor provides dissolution apparatus, automated sampling systems, online UV dissolution systems, and multi-batch automation. Its product range allows laboratories to evaluate configurations based on dosage forms, method requirements, sampling demand, and available analytical capacity.

Q2. Which Raytor systems should laboratories consider for high-throughput dissolution testing?

The RT612-ST supports 12-vessel testing with automated sampling, filtration, and collection. For successive batch processing, the RT9 series includes RT900 for paddle methods and RT910 for basket methods. Selection depends on whether the bottleneck is parallel capacity, sampling, or batch changeover.

Q3. Does the Raytor RT612-ST automatically double laboratory throughput?

No. Its 12-vessel configuration provides parallel testing capacity, but actual output depends on method compatibility, run duration, preparation, cleaning, and downstream analysis. Laboratories should compare completed and reviewed tests per shift rather than infer throughput directly from vessel count.

Q4. What sampling intervals should buyers check for the RT612-ST?

Raytor's published specifications list a three-minute first sampling point and five-minute subsequent routine sampling intervals. Laboratories with closely spaced time points should confirm configuration-specific capabilities and compatibility with their approved methods before purchase.

Q5. How does the RT612-ST support routine method changes?

The RT612-ST uses a coaxial paddle-and-basket design that allows switching without readjusting dissolution-unit height, according to Raytor's product information. This reduces a setup task, although operators must still perform the checks required by their laboratory procedures.